text_1: Angiotensin converting enzyme inhibitors are associated with decreased risk for functional renal insufficiency.
text_2: ARF is most likely to occur when renal perfusion pressure cannot be sustained because of substantial decreases in mean arterial pressure (MAP) or when glomerular filtration rate (GFR) is highly angiotensin II (Ang II) dependent.